Cargando…
Anti-gout Medications and Risk of Cardiovascular Disease: A Nested Case-Control Study
Introduction: Gout is the leading cause of inflammatory arthritis and is also correlated with multiple comorbidities, including cardiovascular disease (CVD), whose future risk can be lowered by urate-lowering therapy (ULT) in gout patients. It is, however, still not clear whether its effect is assoc...
Autores principales: | Chuang, Tsung-Ju, Wang, Yu-Hsun, Wei, James Cheng-Chung, Yeh, Chih-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558358/ https://www.ncbi.nlm.nih.gov/pubmed/34733863 http://dx.doi.org/10.3389/fmed.2021.739680 |
Ejemplares similares
-
Association Between Use of Anti-gout Preparations and Dementia: Nested Case–Control Nationwide Population-Based Cohort Study
por: Chuang, Tsung-Ju, et al.
Publicado: (2021) -
Limited Knee-Joint Range of Motion in Patients With Tophaceous Gout Improved With Medical Treatment: A 18-Months Follow Up
por: Lu, Chuan-Chin, et al.
Publicado: (2020) -
Association between Anti-inflammatory Drug and Dementia in Patients with Gout: A Nationwide, Population-Based Nested Case-Control Study
por: Mikhailichenko, Natalia, et al.
Publicado: (2021) -
The Risk of Gout in Patients with Psoriasis: A Population-Based Cohort Study in Taiwan
por: Wei, James Cheng-Chung, et al.
Publicado: (2022) -
Gout and hyperuricaemia: modifiable cardiovascular risk factors?
por: Burnier, Michel
Publicado: (2023)